The Asia Pacific Parenteral Nutrition Market would witness market growth of 9.3% CAGR during the forecast period (2021-2027).
The consumption of parenteral and amino acid-rich products is driven by the growing cases of hepatic insufficiency, protein-energy malnutrition, and renal insufficiency. Moreover, the substantial enhancements in parenteral nutrition like usage of indirect calorimetry and lipid emulsions optimizations are expected to boost the growth of the parenteral nutrition market in the next few years. Furthermore, some of the factors such as huge spending on the overall growth of the healthcare industry by the government bodies and private enterprises of various nations and increase in the adoption rate of parenteral nutrition products by the healthcare industry are responsible for the growth of the parenteral nutrition market.
Malnutrition is one the most common cause of inflammatory bowel disease (IBD) among a large population in both under-developed and developing countries of this region. As many of the countries of the region were hit hard by the outbreak of the COVID-19 pandemic, parenteral nutrition played a pivotal role in the treatment of the COVID-19 infection-associated malnutrition in patients across the world.
Moreover, the increase in the occurrence of chronic disorders like cancer, Crohn’s disease, HIV, and others are expected to fuel the growth of the regional parenteral nutrition market during the forecasting period. Furthermore, numerous premature babies get nutrition via parenteral nutrition. Intravenous solutions have been a crucial component of the healthcare system of many countries, allowing doctors & nurses to provide hydration to their patients, substitute loss of blood volume, and administer drugs. Therefore, these factors are set to boost the demand for parenteral nutrition in the regional market.
The China market dominated the Asia Pacific Parenteral Lipid Emulsion Market by Country in 2020, thereby, achieving a market value of $205.1 million by 2027. The Japan market is exhibiting a CAGR of 9.5% during (2021 - 2027). Additionally, The India market is poised to grow at a CAGR of 9.5% during (2021 - 2027).
Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Parenteral Nutrition Market is Projected to reach USD 10.9 Billion by 2027, at a CAGR of 8.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.
Scope of the Study
Market Segments Covered in the Report:
By Nutrient Type
- Single Dose Amino Acid Solution
- Parenteral Lipid Emulsion
- Carbohydrates
- Trace Elements,
- Vitamins & Minerals
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B.Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Parenteral Nutrition Market, by Nutrient Type
1.4.2 Asia Pacific Parenteral Nutrition Market, by Asia Pacific
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Parenteral Nutrition Market by Nutrient Type
3.1 Asia Pacific Single Dose Amino Acid Solution Market by Country
3.2 Asia Pacific Parenteral Lipid Emulsion Market by Country
3.3 Asia Pacific Carbohydrates Market by Country
3.4 Asia Pacific Trace Elements Market by Country
3.5 Asia Pacific Other Nutrient Type Market by Country
Chapter 4. Asia Pacific Parenteral Nutrition Market by Country
4.1 China Parenteral Nutrition Market
4.1.1 China Parenteral Nutrition Market by Nutrient Type
4.2 Japan Parenteral Nutrition Market
4.2.1 Japan Parenteral Nutrition Market by Nutrient Type
4.3 India Parenteral Nutrition Market
4.3.1 India Parenteral Nutrition Market by Nutrient Type
4.4 South Korea Parenteral Nutrition Market
4.4.1 South Korea Parenteral Nutrition Market by Nutrient Type
4.5 Singapore Parenteral Nutrition Market
4.5.1 Singapore Parenteral Nutrition Market by Nutrient Type
4.6 Malaysia Parenteral Nutrition Market
4.6.1 Malaysia Parenteral Nutrition Market by Nutrient Type
4.7 Rest of Asia Pacific Parenteral Nutrition Market
4.7.1 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type
Chapter 5. Company Profiles
5.1 Vifor Pharma Management Ltd.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Research & Development Expenses
5.2 Baxter International, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Partnerships, Collaborations, and Agreements:
5.2.1.2 Product Launches and Product Expansions:
5.2.1.3 Approvals and Trails:
5.3 Allergan PLC (AbbVie)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expense
5.4 B. Braun Melsungen AG
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expenses
5.5 Fresenius SE & Co. KGaA
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.6 Grifols S.A.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.7 Pfizer, Inc.
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Regional Analysis
5.7.4 Research & Development Expenses
5.8 ICU Medical, Inc.
5.8.1 Company Overview
5.8.2 Recent strategies and developments:
5.8.2.1 Partnerships, Collaborations, and Agreements:
5.9 Anhui Medipharm Co., Ltd.
5.9.1 Company Overview
5.10. Aculife Healthcare Private Limited
5.10.1 Company Overview
TABLE 1 Asia Pacific Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 3 Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 5 Asia Pacific Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
TABLE 7 Asia Pacific Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
TABLE 9 Asia Pacific Carbohydrates Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Carbohydrates Market by Country, 2021 - 2027, USD Million
TABLE 11 Asia Pacific Trace Elements Market by Country, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Trace Elements Market by Country, 2021 - 2027, USD Million
TABLE 13 Asia Pacific Other Nutrient Type Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Other Nutrient Type Market by Country, 2021 - 2027, USD Million
TABLE 15 Asia Pacific Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
TABLE 17 China Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 18 China Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 19 China Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 20 China Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 21 Japan Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 22 Japan Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 23 Japan Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 24 Japan Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 25 India Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 26 India Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 27 India Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 28 India Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 29 South Korea Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 30 South Korea Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 31 South Korea Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 32 South Korea Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 33 Singapore Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 34 Singapore Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 35 Singapore Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 36 Singapore Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 37 Malaysia Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 38 Malaysia Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 39 Malaysia Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 40 Malaysia Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 41 Rest of Asia Pacific Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 42 Rest of Asia Pacific Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 43 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 44 Rest of Asia Pacific Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 45 Key Information – Vifor Pharma Management Ltd.
TABLE 46 Key Information – Baxter International, Inc.
TABLE 47 Key Information – Allergan PLC
TABLE 48 key Information – B. Braun Melsungen AG
TABLE 49 key information – Fresenius SE & Co. KGaA
TABLE 50 key information – Grifols S.A.
TABLE 51 Key Information – Pfizer, Inc.
TABLE 52 key information – ICU Medical, Inc.
TABLE 53 Key Information – Anhui Medipharm Co., Ltd.
TABLE 54 Key Information – ACULIFE HEALTHCARE PRIVATE LIMITED
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Baxter International, Inc.